Potential In Yeast For Selecting Lou Gehrig’s Disease Drugs
May 15th 2008Drug InformationMultiple Sclerosis
Researchers from the University of Pennsylvania School of Medicine are developing a novel approach to screen for drugs to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, using yeast cells. In recent months a number of mutations have been found in a disease protein called TDP-43, which is implicated in ALS and certain types of frontotemporal dementia (FTD).
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
